CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-07 | Wang Xiaodong Director | Option exercise · Share Option (Right to Buy) 10b5-1 | −542,880 | 2,714,407 | ||
| 2024-12-14 | OYLER JOHN Chief Executive Officer | Option exercise | +1,300,000 | $0.50 | $650K | 2,978,833 |
| 2024-12-14 | OYLER JOHN Chief Executive Officer | Option exercise · Share Option (Right to Buy) | −1,300,000 | 10,100,500 | ||
| 2024-12-10 | Wang Xiaodong Director | Option exercise 10b5-1 | +41,760 | $6.50 | $271K | 41,760 |
| 2024-12-10 | Wang Xiaodong Director | Sale 10b5-1 | −2,600 | $183.60 | $477K | 39,160 |
| 2024-12-10 | Wang Xiaodong Director | Sale 10b5-1 | −7,063 | $184.83 | $1.3M | 32,097 |
| 2024-12-10 | Wang Xiaodong Director | Sale 10b5-1 | −9,956 | $185.73 | $1.8M | 22,141 |
| 2024-12-10 | Wang Xiaodong Director | Sale 10b5-1 | −9,266 | $186.99 | $1.7M | 12,875 |
| 2024-12-10 | Wang Xiaodong Director | Sale 10b5-1 | −6,350 | $187.60 | $1.2M | 6,525 |
| 2024-12-10 | Wang Xiaodong Director | Sale 10b5-1 | −1,300 | $188.79 | $245K | 5,225 |
| 2024-12-10 | Wang Xiaodong Director | Sale 10b5-1 | −1,833 | $190.57 | $349K | 3,392 |
| 2024-12-10 | Wang Xiaodong Director | Sale 10b5-1 | −993 | $191.78 | $190K | 2,399 |
| 2024-12-10 | Wang Xiaodong Director | Sale 10b5-1 | −1,374 | $192.61 | $265K | 1,025 |
| 2024-12-10 | Wang Xiaodong Director | Sale 10b5-1 | −725 | $194.01 | $141K | 300 |
| 2024-12-10 | Wang Xiaodong Director | Sale 10b5-1 | −300 | $195.67 | $59K | 0 |
| 2024-12-10 | Wang Xiaodong Director | Option exercise · Share Option (Right to Buy) 10b5-1 | −542,880 | 3,257,287 | ||
| 2024-12-09 | BAKER BROS. ADVISORS LP Director | Sale | −3,074 | $208.01 | $639K | 874,529 |
| 2024-12-09 | BAKER BROS. ADVISORS LP Director | Sale | −33,943 | $208.01 | $7.1M | 9,657,351 |
| 2024-12-09 | BAKER BROS. ADVISORS LP Director | Sale | −83,036 | $186.50 | $15.5M | 791,493 |
| 2024-12-09 | BAKER BROS. ADVISORS LP Director | Sale | −916,964 | $186.50 | $171.0M | 8,740,387 |
Page 34 of 71 · 1,406 trades